Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Abu Dhabi’s off-plan property market achieved record levels in 2025, according to new analysis by MERED, the award-winning international real estate developer. City-wide sales volume surged to 1.17 million sqm, nearly double the previous year’s total and exceeding the combined volume of the past three years. Spearheading this expansion, Al Reem Island dramatically outperformed, with […] The post Al Reem Island Sales Volume More Than Tripled in 2025, MERED Analysis Shows 45% Price Surge appeared first on Web-Release.